COMMUNIQUÉS West-GlobeNewswire

Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent
02/11/2018
Press release November 2, 2018 Enzymatica's rights issue is secured up to 100 percent Enzymatica announced on October 18, 2018 that the Board of Directors has decided to carry out a rights issue of a maximum of SEK 98.7 [...]
Curetis launches privately placed capital increase to raise up to €18.4 million
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO [...]
Rule 2.9 Announcement
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 2 November 2018 [...]
OSE Immunotherapeutics Regains Worldwide Rights to its CD28 antagonist FR104 from Janssen Biotech
02/11/2018
OSE to pursue clinical development of FR104 to treat autoimmune diseases FR104’s good phase 1 clinical safety profile and first efficacy signal support phase 2 testing NANTES, France, Nov. 02, 2018 (GLOBE NEWSWIRE) -- [...]
INNATE PHARMA : clinical data featured as oral presentations at two major upcoming oncology conferences
02/11/2018
INNATE PHARMA CLINICAL DATA FEATURED AS ORAL PRESENTATIONS AT TWO MAJOR UPCOMING ONCOLOGY CONFERENCES Late-breaking abstract and oral presentation on clinical and translational biomarker results from the combination of [...]
INNATE PHARMA annonce la présentation de données cliniques à deux prochains congrès majeurs d'oncologie
02/11/2018
Innate Pharma annonce la présentation de données cliniques lors de sessions orales à deux prochains congrès majeurs d'oncologie Présentation orale de résultats cliniques et translationnels sur les biomarqueurs de la [...]
Abiomed annonce un chiffre d'affaires record de 182 millions $ pour le deuxième trimestre 2019, soit une hausse de 37 % par rapport au trimestre équivalent de l'exercice précédent
02/11/2018
DANVERS, Massachusetts, 02 nov. 2018 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ: ABMD), un fournisseur majeur de technologies innovantes de récupération et d'assistance cardiaque, a annoncé aujourd'hui un chiffre d' [...]
VANC Pharmaceuticals Inc. Provides Corporate Update
02/11/2018
VANCOUVER, British Columbia, Nov. 01, 2018 (GLOBE NEWSWIRE) -- VANC Pharmaceuticals Inc. ( “VANC” ) is excited to announce that further to its news release announced October 25, 2018, the Company has received TSX [...]
CV Sciences, Inc. to Sponsor 25th Anniversary HIACON Conference in Los Angeles, California on Nov 2-5, 2018
01/11/2018
As 2018 Farm Bill Momentum Rises, CV Sciences and Hemp Industries Association are ‘Charting The Course’ LAS VEGAS, Nov. 01, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB: CVSI) preeminent supplier and manufacturer [...]
New learning technology adds ‘significant boost’ to prescribing safety in Canada
01/11/2018
LONDON and OTTAWA, Nov. 01, 2018 (GLOBE NEWSWIRE) -- The Royal College of Physicians and Surgeons of Canada (Royal College) has today taken a vital step towards championing Canadian patient safety, by introducing a [...]
De nouveaux modules d’apprentissage renforcent les compétences en prescription au Canada
01/11/2018
LONDRES et OTTAWA , 01 nov. 2018 (GLOBE NEWSWIRE) -- Le Collège royal des médecins et chirurgiens du Canada (Collège royal) s’affirme une fois de plus en tant qu’ardent défenseur de la sécurité des patients canadiens en [...]
Portola Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (NASDAQ: PTLA) announced today that on October 26, 2018, the Compensation Committee of the Board of Directors approved, [...]
Diversicare Announces 2018 Third Quarter Results
01/11/2018
BRENTWOOD, Tenn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of long-term care services, today announced its results for the third quarter ended September [...]
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months of 2018
01/11/2018
Q3 2018 performance in line with guidance Revises full year 2018 financial forecast to reflect anticipated strong full year organic business performance, expected at the higher end of the previous forecast, and impact [...]
IHMA annonce une nouvelle entreprise en Inde pour renforcer son soutien mondial au développement de médicaments anti-infectieux pour l'industrie biopharmaceutique
01/11/2018
SCHAUMBURG, Illinois, 01 nov. 2018 (GLOBE NEWSWIRE) -- International Health Management Associates, Inc. / IHMA Europe Sàrl (IHMA), société mondiale qui propose des services de laboratoire et de consultation à l' [...]
Agile Therapeutics Reports Third Quarter 2018 Financial Results
01/11/2018
Cash Expected to Enable Company to Fund Operations into Second Quarter 2019 PRINCETON, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today reported [...]
Neon Therapeutics to Host Investor Event at Society for Immunotherapy of Cancer 33rd Annual Meeting
01/11/2018
CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced that it will host an [...]
Adverum Biotechnologies Provides Program Updates
01/11/2018
Preliminary data from the ADVANCE Phase 1/2 Study in A1AT deficiency showed ADVM-043 in doses of up to 1.5 x 10 13 vg/kg were safely administered and well tolerated; Protein expression did not meet a clinically [...]
Novavax to Host Conference Call to Discuss Third Quarter Financial Results on November 7, 2018
01/11/2018
GAITHERSBURG, Md., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) today announced it will report its third quarter 2018 financial and operating results following the close of U.S. financial markets on [...]

Pages